Home/Ankasa Regenerative Therapeutics/Sanford J. Madigan, Ph.D.
SJ

Sanford J. Madigan, Ph.D.

CEO

Ankasa Regenerative Therapeutics

Ankasa Regenerative Therapeutics Pipeline

DrugIndicationPhase
ART352-LAugmentation of autograft in spinal fusion surgeryPre-clinical